The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Scott K. Fridkin

Hospital Infections Program

National Center for Infectious Diseases

Centers for Disease Control and Prevention

Atlanta

USA

[email]@cdc.gov

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, USA. 1999 - 2005
  • Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. 2002

References

  1. Methicillin-resistant Staphylococcus aureus disease in three communities. Fridkin, S.K., Hageman, J.C., Morrison, M., Sanza, L.T., Como-Sabetti, K., Jernigan, J.A., Harriman, K., Harrison, L.H., Lynfield, R., Farley, M.M. N. Engl. J. Med. (2005) [Pubmed]
  2. The changing face of fungal infections in health care settings. Fridkin, S.K. Clin. Infect. Dis. (2005) [Pubmed]
  3. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Fridkin, S.K., Hageman, J., McDougal, L.K., Mohammed, J., Jarvis, W.R., Perl, T.M., Tenover, F.C. Clin. Infect. Dis. (2003) [Pubmed]
  4. Routine cycling of antimicrobial agents as an infection-control measure. Fridkin, S.K. Clin. Infect. Dis. (2003) [Pubmed]
  5. Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Fridkin, S.K., Hill, H.A., Volkova, N.V., Edwards, J.R., Lawton, R.M., Gaynes, R.P., McGowan, J.E. Emerging Infect. Dis. (2002) [Pubmed]
  6. Monitoring antimicrobial use and resistance: comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant enterococci. Fridkin, S.K., Lawton, R., Edwards, J.R., Tenover, F.C., McGowan, J.E., Gaynes, R.P. Emerging Infect. Dis. (2002) [Pubmed]
  7. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Fridkin, S.K. Clin. Infect. Dis. (2001) [Pubmed]
  8. Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections. Fridkin, S.K., Edwards, J.R., Tenover, F.C., Gaynes, R.P., McGowan, J.E. Clin. Infect. Dis. (2001) [Pubmed]
  9. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Fridkin, S.K., Edwards, J.R., Courval, J.M., Hill, H., Tenover, F.C., Lawton, R., Gaynes, R.P., McGowan, J.E. Ann. Intern. Med. (2001) [Pubmed]
  10. Antimicrobial resistance in intensive care units. Fridkin, S.K., Gaynes, R.P. Clin. Chest Med. (1999) [Pubmed]
  11. Determinants of vancomycin use in adult intensive care units in 41 United States hospitals. Fridkin, S.K., Edwards, J.R., Pichette, S.C., Pryor, E.R., McGowan, J.E., Tenover, F.C., Culver, D.H., Gaynes, R.P. Clin. Infect. Dis. (1999) [Pubmed]
  12. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Fridkin, S.K., Steward, C.D., Edwards, J.R., Pryor, E.R., McGowan, J.E., Archibald, L.K., Gaynes, R.P., Tenover, F.C. Clin. Infect. Dis. (1999) [Pubmed]
 
WikiGenes - Universities